Thailand · Delayed Price · Currency is THB Medeze Group PCL Statistics
Total Valuation
BKK:MEDEZE has a market cap or net worth of THB 6.94 billion. The enterprise value is 5.27 billion.
| Market Cap | 6.94B |
| Enterprise Value | 5.27B |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | Apr 29, 2026 |
Share Statistics
BKK:MEDEZE has 1.07 billion shares outstanding. The number of shares has increased by 14.93% in one year.
| Current Share Class | 1.07B |
| Shares Outstanding | 1.07B |
| Shares Change (YoY) | +14.93% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 42.30% |
| Owned by Institutions (%) | n/a |
| Float | 245.83M |
Valuation Ratios
The trailing PE ratio is 44.47 and the forward PE ratio is 27.08. BKK:MEDEZE's PEG ratio is 0.72.
| PE Ratio | 44.47 |
| Forward PE | 27.08 |
| PS Ratio | 9.43 |
| PB Ratio | 2.33 |
| P/TBV Ratio | 2.34 |
| P/FCF Ratio | 112.26 |
| P/OCF Ratio | 34.28 |
| PEG Ratio | 0.72 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.90, with an EV/FCF ratio of 85.21.
| EV / Earnings | 33.75 |
| EV / Sales | 7.16 |
| EV / EBITDA | 22.90 |
| EV / EBIT | 27.90 |
| EV / FCF | 85.21 |
Financial Position
The company has a current ratio of 15.25, with a Debt / Equity ratio of 0.01.
| Current Ratio | 15.25 |
| Quick Ratio | 14.69 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.08 |
| Debt / FCF | 0.29 |
| Interest Coverage | 8.39 |
Financial Efficiency
Return on equity (ROE) is 5.22% and return on invested capital (ROIC) is 13.31%.
| Return on Equity (ROE) | 5.22% |
| Return on Assets (ROA) | 3.34% |
| Return on Invested Capital (ROIC) | 13.31% |
| Return on Capital Employed (ROCE) | 5.52% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 3.68M |
| Profits Per Employee | 780,584 |
| Employee Count | 200 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 4.71 |
Taxes
In the past 12 months, BKK:MEDEZE has paid 16.47 million in taxes.
| Income Tax | 16.47M |
| Effective Tax Rate | 9.55% |
Stock Price Statistics
The stock price has decreased by -1.48% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -1.48% |
| 50-Day Moving Average | 6.16 |
| 200-Day Moving Average | 6.46 |
| Relative Strength Index (RSI) | 62.92 |
| Average Volume (20 Days) | 753,037 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BKK:MEDEZE had revenue of THB 735.80 million and earned 156.12 million in profits. Earnings per share was 0.15.
| Revenue | 735.80M |
| Gross Profit | 544.64M |
| Operating Income | 188.89M |
| Pretax Income | 172.59M |
| Net Income | 156.12M |
| EBITDA | 222.02M |
| EBIT | 188.89M |
| Earnings Per Share (EPS) | 0.15 |
Balance Sheet
The company has 1.69 billion in cash and 17.95 million in debt, with a net cash position of 1.67 billion or 1.57 per share.
| Cash & Cash Equivalents | 1.69B |
| Total Debt | 17.95M |
| Net Cash | 1.67B |
| Net Cash Per Share | 1.57 |
| Equity (Book Value) | 2.98B |
| Book Value Per Share | 2.79 |
| Working Capital | 1.69B |
Cash Flow
In the last 12 months, operating cash flow was 202.50 million and capital expenditures -140.66 million, giving a free cash flow of 61.84 million.
| Operating Cash Flow | 202.50M |
| Capital Expenditures | -140.66M |
| Depreciation & Amortization | 33.12M |
| Net Borrowing | -8.21M |
| Free Cash Flow | 61.84M |
| FCF Per Share | 0.06 |
Margins
Gross margin is 74.02%, with operating and profit margins of 25.67% and 21.22%.
| Gross Margin | 74.02% |
| Operating Margin | 25.67% |
| Pretax Margin | 23.46% |
| Profit Margin | 21.22% |
| EBITDA Margin | 30.17% |
| EBIT Margin | 25.67% |
| FCF Margin | 8.40% |
Dividends & Yields
This stock pays an annual dividend of 0.16, which amounts to a dividend yield of 2.46%.
| Dividend Per Share | 0.16 |
| Dividend Yield | 2.46% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 109.42% |
| Buyback Yield | -14.93% |
| Shareholder Yield | -12.53% |
| Earnings Yield | 2.25% |
| FCF Yield | 0.89% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for BKK:MEDEZE is 8.20, which is 24.24% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 8.20 |
| Price Target Difference | 24.24% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 28.60% |
| EPS Growth Forecast (3Y) | 35.72% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BKK:MEDEZE has an Altman Z-Score of 8.81 and a Piotroski F-Score of 4.
| Altman Z-Score | 8.81 |
| Piotroski F-Score | 4 |